Navidea Biopharmaceuticals Inc Insider ownership
What is the Insider ownership of Navidea Biopharmaceuticals Inc?
The Insider ownership of Navidea Biopharmaceuticals Inc is 31.37%
What is the definition of Insider ownership?
Insider Ownership is calculated as the total number of shares owned by insiders (shareholders who own more than 5% of the corporation or an officer or director of the company) divided by the total Shares Outstanding.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Insider ownership of companies in the Health Care sector on NYSEMKT compared to Navidea Biopharmaceuticals Inc
What does Navidea Biopharmaceuticals Inc do?
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Companies with insider ownership similar to Navidea Biopharmaceuticals Inc
- Oasmia Pharmaceutical AB (publ) has Insider ownership of 31.31%
- Tianjin Jiuri New Materials Co has Insider ownership of 31.31%
- GoCo Plc has Insider ownership of 31.35%
- Kingold Jewelry Inc has Insider ownership of 31.36%
- Dash Capital Corp has Insider ownership of 31.36%
- Begbies Traynor plc has Insider ownership of 31.37%
- Navidea Biopharmaceuticals Inc has Insider ownership of 31.37%
- China Water Industry has Insider ownership of 31.37%
- Voltas has Insider ownership of 31.37%
- Titomic has Insider ownership of 31.37%
- Saga Plc has Insider ownership of 31.38%
- Alicanto Minerals has Insider ownership of 31.38%
- Trek Metals has Insider ownership of 31.38%